Decreased Expression of the Human Urea Transporter SLC14A1 in Bone is Induced by Cytokines and Stimulates Adipogenesis of Mesenchymal Progenitor Cells

Abstract

The human urea transporter SLC14A1 (HUT11/UT-B) has been suggested as a marker for the adipogenic differentiation of bone cells with a relevance for bone diseases. We investigated the function of SLC14A1 in different cells models from bone environment. SLC14A1 expression and cytokine production was investigated in bone cells obtained from patients with osteoporosis. Gene and protein expression of SLC14A1 was studied during adipogenic or osteogenic differentiation of human mesenchymal progenitor cells (hMSCs) and of the single-cell–derived hMSC line (SCP-1), as well as in osteoclasts and chondrocytes. Localization was determined by histochemical methods and functionality by urea transport experiments. Expression of SLC14A1 mRNA was lower in cells from patients with osteoporosis that produced high levels of cytokines. Accordingly, when adding a combination of cytokines to SCP-1 SLC14A1 mRNA expression decreased. SLC14A1 mRNA expression decreased after both osteogenic and more pronounced adipogenic stimulation of hMSCs and SCP-1 cells. The highest SLC14A1 expression was determined in undifferentiated cells, lowest in chondrocytes and osteoclasts. Downregulation of SLC14A1 by siRNA resulted in an increased expression of interleukin-6 and interleukin-1 beta as well as adipogenic markers. Urea influx through SLC14A1 increased expression of osteogenic markers, adipogenic markers were suppressed. SLC14A1 protein was localized in the cell membrane and the cytoplasm. Summarizing, the SLC14A1 urea transporter affects early differentiation of hMSCs by diminishing osteogenesis or by favoring adipogenesis, depending on its expression level. Therefore, SLC14A1 is not unequivocally an adipogenic marker in bone. Our findings suggest an involvement of SLC14A1 in bone metabolism and inflammatory processes and disease-dependent influences on its expression.

Publikationsverlauf

Artikel online veröffentlicht:
20. Januar 2020

• References

• 1 Pittenger MF, Mackay AM, Beck SC. et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
• 2 Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004; 4: 290-294
• 3 Beresford JN, Bennett JH, Devlin C. et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102: 341-351
• 4 Thompson DL, Lum KD, Nygaard SC. et al. The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: New insights into osteoblast and adipocyte differentiation. J Bone Miner Res 1998; 13: 195-204
• 5 Noth U, Osyczka AM, Tuli R. et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002; 20: 1060-1069
• 6 Ahdjoudj S, Fromigue O, Marie PJ. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: Potential implication in the treatment of age-related bone loss. Histol Histopathol 2004; 19: 151-157
• 7 Li J, Zuo B, Zhang L. et al. Osteoblast versus Adipocyte: Bone Marrow Microenvironment-guided Epigenetic control. Case Rep Orthop Res 2018; Vol1: 2-18
• 8 Abdallah BM, Kassem M. New factors controlling the balance between osteoblastogenesis and adipogenesis. Bone 2012; 50: 540-545 doi:10.1016/j.bone.2011.06.030
• 9 Chan GK, Duque G. Age-related bone loss: Old bone, new facts. Gerontology 2002; 48: 62-71 48929
• 10 Naot D, Cornish J. Cytokines and hormones that contribute to the positive association between fat and bone. Front Endocrinol 2014; 5: 70 doi:10.3389/fendo.2014.00070
• 11 Blaschke M, Koepp R, Cortis J. et al. IL-6, IL-1beta, and TNF-alpha only in combination influence the osteoporotic phenotype in Crohn’s patients via bone formation and bone resorption. Adv Clin Exp Med 2018; 27: 45-56
• 12 Manolagas SC. Role of cytokines in bone resorption. Bone 1995; 17: 63S-67S
• 13 Pacifici R, Brown C, Puscheck E. et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88: 5134-5138
• 14 Spelsberg TC, Subramaniam M, Riggs BL. et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999; 13: 819-828
• 15 Olives B, Neau P, Bailly P. et al. Cloning and functional expression of a urea transporter from human bone marrow cells. J Biol Chem 1994; 269: 31649-31652
• 16 Prichett WP, Patton AJ, Field JA. et al. Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone. J Cell Biochem 2000; 76: 639-650
• 17 Stewart G. The emerging physiological roles of the SLC14A family of urea transporters. Br J Pharmacol 2011; 164: 1780-1792 doi:10.1111/j.1476-5381.2011.01377.x
• 18 MacPherson H, Noble BS, Ralston SH. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells. Bone 1999; 24: 179-185
• 19 Fan X, Roy E, Zhu L. et al. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 2004; 145: 751-759
• 20 van't Hof RJ, Macphee J, Libouban H. et al. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 2004; 145: 5068-5074
• 21 Xu XH, Dong SS, Guo Y. et al. Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev 2010; 31: 447-505
• 22 Hopwood B, Tsykin A, Findlay DM. et al. Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 2009; 44: 87-101
• 23 Smith CP. Mammalian urea transporters. Exp Physiol 2009; 94: 180-185 doi:10.1113/expphysiol.2008.043042
• 24 Bocker W, Yin Z, Drosse I. et al. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med 2008; 12: 1347-1359
• 25 Siggelkow H, Schulz H, Kaesler S. et al. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcif Tissue Int 1999; 64: 414-421
• 26 Siggelkow H, Eidner T, Lehmann G. et al. Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J Bone Miner Res 2003; 18: 529-538
• 27 Siggelkow H, Hilmes D, Robenstorff K. et al. Analysis of human primary bone cells by fluorescence activated cell scanning: Methodological problems and preliminary results. Clin Chim Acta 1998; 272: 111-125
• 28 Siggelkow HBK, Atkinson MJ, Hüfner M. Phenotypic stability of primary human osteoblast-like cells at different cell densities and passage numbers. Exp Clin Endocr Diab 1998; 106: 217-225
• 29 Siggelkow H, Rebenstorff K, Kurre W. et al. Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 1999; 75: 22-35
• 30 Ponce ML, Koelling S, Kluever A. et al. Coexpression of osteogenic and adipogenic differentiation markers in selected subpopulations of primary human mesenchymal progenitor cells. J Cell Biochem 2008; 104: 1342-1355
• 31 Hauselmann HJ, Fernandes RJ, Mok SS. et al. Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci 1994; 107: 17-27
• 32 Lutter AH, Hempel U, Wolf-Brandstetter C. et al. A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix. J Cell Biochem 2010; 109: 1025-1032
• 33 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408
• 34 Siggelkow H, Schmidt E, Hennies B. et al. Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts. Bone 2004; 35: 570-576
• 35 Siebert PD, Larrick JW. PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques 1993; 14: 244-249
• 36 Koelling S, Kruegel J, Irmer M. et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009; 4: 324-335
• 37 Albert JS, Bhattacharyya N, Wolfe LA. et al. Impaired osteoblast and osteoclast function characterize the osteoporosis of Snyder - Robinson syndrome. Orphanet J Rare Dis 2015; 10: 27
• 38 van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001; 103: 255-261
• 39 You G, Smith CP, Kanai Y. et al. Cloning and characterization of the vasopressin-regulated urea transporter. Nature 1993; 365: 844-847
• 40 Turk N, Cukovic-Cavka S, Korsic M. et al. Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn’s disease. Eur J Gastroen Hepat 2009; 21: 159-166
• 41 Roodman GD. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993; 53 S94-S98
• 42 Blaschke M, Koepp R, Lenz C. et al. Crohn's disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients' disease stage and to bone mineral density. J Clin Transl Endocrinol 2018; 13: 26-38
• 43 Schmidt C, Hocherl K, Bucher M. Cytokine-mediated regulation of urea transporters during experimental endotoxemia. Am J Physiol Renal Physiol 2007; 292: F1479-F1489 doi:10.1152/ajprenal.00460.2006
• 44 Trujillo ME, Sullivan S, Harten I. et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 2004; 89: 5577-5582
• 45 Owen TA, Aronow M, Shalhoub V. et al. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420-430
• 46 Ahmed AS, Sheng MH, Wasnik S. et al. Effect of aging on stem cells. World J Exp Med 2017; 7: 1-10
• 47 Jilka RL, Hangoc G, Girasole G. et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992; 257: 88-91
• 48 Rothman S. How is the balance between protein synthesis and degradation achieved?. Theor Biol Med Model 2010; 7: 25 doi:10.1186/1742-4682-7-25
• 49 Toyama BH, Hetzer MW. Protein homeostasis: Live long, won't prosper. Nat Rev Mol Cell Biol 2013; 14: 55-61 doi:10.1038/nrm3496
• 50 Eden E, Geva-Zatorsky N, Issaeva I. et al. Proteome half-life dynamics in living human cells. Science 2011; 331: 764-768
• 51 Chan PY, Cossins EA. Regulation of arginase levels by urea and intermediates of the Krebs-Henseleit cycle in Saccharomyces cerevisiae. FEBS letters 1972; 19: 335-339
• 52 Sun Y, Lau CW, Jia Y. et al. Functional inhibition of urea transporter UT-B enhances endothelial-dependent vasodilatation and lowers blood pressure via L-arginine-endothelial nitric oxide synthase-nitric oxide pathway. Sci Rep 2016; 6: 18697
• 53 Agostinelli E, Marques MP, Calheiros R. et al. Polyamines: fundamental characters in chemistry and biology. Amino Acids 2010; 38: 393-403
• 54 Ishii I, Ikeguchi Y, Mano H. et al. Polyamine metabolism is involved in adipogenesis of 3T3-L1 cells. Amino Acids 2012; 42: 619-626
• 55 Büyükuslu NÖ, Polyamine RI. metabolism and obesity: Polyamine metabolic enzymes involved in obesity. Acta Pharma. Sci 2018; 56 doi:10.23893/1307-2080.APS.05613
• 56 Brenner S, Bercovich Z, Feiler Y. et al. Dual regulatory role of polyamines in adipogenesis. J Biol Chem 2015; 290: 27384-27392
• 57 Zayzafoon M, Botolin S, McCabe LR. P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem 2002; 277: 37212-37218
• 58 Li YM, Schilling T, Benisch P. et al. Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 2007; 363: 209-215
• 59 Fibbi B, Benvenuti S, Giuliani C. et al. Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: A novel mechanism for chronic hyponatremia-induced bone loss. Endocrine. 2016; 52: 73-85
• 60 Hankamolsiri W, Manochantr S, Tantrawatpan C. et al. The effects of high glucose on adipogenic and osteogenic differentiation of gestational tissue-derived MSCs. Stem Cells Int 2016;
• 61 Klein JD, Blount MA, Sands JM. Urea transport in the kidney. Compr Physiol 2011; 1: 699-729
• 62 Klein JD, Blount MA, Sands JM. Molecular mechanisms of urea transport in health and disease. Pflugers Arch. 2012; 464: 561-572
• 63 Moe SM, Drueke T, Lameire N. et al. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 2007; 14: 3-12